Regenxbio Inc (RGNX)

Payables turnover

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cost of revenue	US$ in thousands	146,758	152,726	138,197	115,616	67,208
Payables	US$ in thousands	22,786	27,213	11,387	10,622	6,409
Payables turnover		6.44	5.61	12.14	10.88	10.49

December 31, 2023 calculation

Payables turnover = Cost of revenue ÷ Payables
= $146,758K ÷ $22,786K
= 6.44

Regenxbio Inc's payables turnover has exhibited variability over the five-year period from 2019 to 2023. The payables turnover ratio, which measures how efficiently a company is managing its trade credit by paying its suppliers, has fluctuated significantly. In 2021 and 2022, the company's payables turnover ratios were relatively high at 4.36 and 2.00, respectively, indicating that Regenxbio was making payments to its suppliers more frequently during these years.

However, in 2020 and 2013, the payables turnover ratios decreased to 4.11 and 1.63, respectively, suggesting that Regenxbio took longer to pay off its trade payables during these periods. The low payables turnover ratio in 2019 at 1.29 indicates that the company might have been holding onto its payables for a longer period before settling its obligations with suppliers.

Overall, the fluctuating trend in Regenxbio's payables turnover ratios suggests varying payment practices and liquidity management strategies employed by the company over the years. Further analysis of the company's financial health and supplier relationships would be required to fully understand the reasons behind these fluctuations and their potential impact on Regenxbio's operations and financial performance.